Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-28 @ 12:09 PM
Study NCT ID:
NCT01802450
Status:
UNKNOWN
Last Update Posted:
2015-09-17
First Post:
2013-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
Sponsor:
PETHEMA Foundation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DASAPOST
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None